» Articles » PMID: 35525255

Long-term Secondary Prevention of Cardiovascular Disease with a Mediterranean Diet and a Low-fat Diet (CORDIOPREV): a Randomised Controlled Trial

Abstract

Background: Mediterranean and low-fat diets are effective in the primary prevention of cardiovascular disease. We did a long-term randomised trial to compare the effects of these two diets in secondary prevention of cardiovascular disease.

Methods: The CORDIOPREV study was a single-centre, randomised clinical trial done at the Reina Sofia University Hospital in Córdoba, Spain. Patients with established coronary heart disease (aged 20-75 years) were randomly assigned in a 1:1 ratio by the Andalusian School of Public Health to receive a Mediterranean diet or a low-fat diet intervention, with a follow-up of 7 years. Clinical investigators (physicians, investigators, and clinical endpoint committee members) were masked to treatment assignment; participants were not. A team of dietitians did the dietary interventions. The primary outcome (assessed by intention to treat) was a composite of major cardiovascular events, including myocardial infarction, revascularisation, ischaemic stroke, peripheral artery disease, and cardiovascular death. This study is registered with ClinicalTrials.gov, NCT00924937.

Findings: From Oct 1, 2009, to Feb 28, 2012, a total of 1002 patients were enrolled, 500 (49·9%) in the low-fat diet group and 502 (50·1%) in the Mediterranean diet group. The mean age was 59·5 years (SD 8·7) and 827 (82·5%) of 1002 patients were men. The primary endpoint occurred in 198 participants: 87 in the Mediterranean diet group and 111 in the low-fat group (crude rate per 1000 person-years: 28·1 [95% CI 27·9-28·3] in the Mediterranean diet group vs 37·7 [37·5-37·9] in the low-fat group, log-rank p=0·039). Multivariable-adjusted hazard ratios (HRs) of the different models ranged from 0·719 (95% CI 0·541-0·957) to 0·753 (0·568-0·998) in favour of the Mediterranean diet. These effects were more evident in men, with primary endpoints occurring in 67 (16·2%) of 414 men in the Mediterranean diet group versus 94 (22·8%) of 413 men in the low-fat diet group (multiadjusted HR 0·669 [95% CI 0·489-0·915], log-rank p=0·013), than in 175 women for whom no difference was found between groups.

Interpretation: In secondary prevention, the Mediterranean diet was superior to the low-fat diet in preventing major cardiovascular events. Our results are relevant to clinical practice, supporting the use of the Mediterranean diet in secondary prevention.

Funding: Fundacion Patrimonio Comunal Olivarero; Fundacion Centro para la Excelencia en Investigacion sobre Aceite de Oliva y Salud; local, regional, and national Spanish Governments; European Union.

Citing Articles

Translating Evidence for a Mediterranean-Style Dietary Pattern into Routine Care for Coronary Heart Disease and Type 2 Diabetes: Implementation and Evaluation in a Targeted Public Health Service in Australia.

Mayr H, Hayes L, Wang W, Murray E, Kelly J, Palmer M Healthcare (Basel). 2025; 13(5).

PMID: 40077068 PMC: 11898626. DOI: 10.3390/healthcare13050506.


Comment on: Mediterranean diet enriched with Olive oil shows no con-sistent benefits on cardiometabolic and anthropometric param-eters: a systematic review with meta-analysis of randomized controlled trials.

Martinez-Gonzalez M, Visioli F Eur J Nutr. 2025; 64(3):118.

PMID: 40063229 DOI: 10.1007/s00394-025-03619-8.


Response to: comment on: Mediterranean diet enriched with Olive oil shows no con-sistent benefits on cardiometabolic and anthropometric param-eters: a systematic review with meta-analysis of randomized controlled trials.

Keshani M Eur J Nutr. 2025; 64(3):119.

PMID: 40063171 DOI: 10.1007/s00394-025-03620-1.


MiRNAs as biomarkers of nutritional therapy to achieve T2DM remission in patients with coronary heart disease: from the CORDIOPREV study.

Alcala-Diaz J, Camargo A, Vals-Delgado C, Leon-Acuna A, Garcia-Fernandez H, Arenas-de Larriva A Nutr Diabetes. 2025; 15(1):7.

PMID: 39987252 PMC: 11846967. DOI: 10.1038/s41387-025-00362-1.


Interacting and joint effects of frailty and inflammation on cardiovascular disease risk and the mediating role of inflammation in middle-aged and elderly populations.

Xu Z, Wang Y, Li X, Hou X, Yue S, Wang J BMC Cardiovasc Disord. 2025; 25(1):118.

PMID: 39979798 PMC: 11841180. DOI: 10.1186/s12872-025-04567-1.